FDA recall, , Moderate risk
Becton Dickinson BD GasPak EZ CO2 and Campy Pouch Systems
BD GasPak EZ CO2 Pouch System may produce carbon dioxide levels below specification.
Summary by Recall Canary from the FDA notice
What happened
Becton Dickinson & Co. of Sparks, Maryland, recalled certain lots of BD GasPak EZ CO2 Pouch System and BD GasPak EZ Campy Pouch System, both for microbiologic use, because gas generating sachets may produce carbon dioxide levels below specification. The recall began April 7, 2026, and was added to the FDA's Enforcement Report on April 29, 2026, with distribution nationwide and in Hong Kong.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is your pouch affected?
2 products
Match the UDI-DI and lot code listed under your product.
A UDI-DI is the device identifier printed with the barcode on the device label.
BD GasPak EZ CO2 Pouch System. Catalog Number: 260684. for microbiologic use
- UDI-DI
- 30382902606841
- Lot code
- 5303157
- 5329857
- 5329860
BD GasPak EZ Campy Pouch System. Catalog Number: 260685. for microbiologic use
- UDI-DI
- 30382902606858
- Lot code
- 5329863
Recall details
- Company began the recall
- Sold in
Worldwide distribution - US Nationwide and the country of Hong Kong.
- Company
- Becton Dickinson & Co.Sparks, Maryland
- Hazard
- Device defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98657
- Recall numbers
- Z-1982-2026 to Z-1983-2026
All recalls from Becton Dickinson & Co.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
